Literature DB >> 10936070

Molecular bases for the development of hepatitis B virus (HBV)-related hepatocellular carcinoma (HCC).

C Bréchot1, D Gozuacik, Y Murakami, P Paterlini-Bréchot.   

Abstract

Hepatocellular carcinoma (HCC) is the most common histological form of primary liver cancer; the tumor cells having retained features of hepatocytic differentiation. It is important to emphasize the heterogeneity of the histological background on which the tumor develops. Most HCCs complicate the evolution of an active or inactive cirrhosis. However, some tumors occur on livers with minimal histological changes; the prevalence of such cases varies from one geographical region to the other; being much higher in the southern half of Africa (around 40% of HCCs) than in Asia, America and Europe, where at least 90% of HCCs are associated in the cirrhosis. This heterogeneity is probably a reflection of different environmental and genetic factors. A large number of epidemiological and molecular studies have indeed clearly demonstrated the prime importance of environmental factors to the development of primary liver cancers in humans. Chronic hepatitis B (HBV) and C (HCV) infections are major risk factors. This review will mainly analyse the impact of chronic HBV infection but it is important to emphasize the potential synergistic effects between HBV and HCV, as well as between viral infections and other environmental factors, such as alcohol, chemical carcinogens (see review by Dr Wogan) and other, still poorly defined, hormonal factors which may account for the higher incidence of the tumor in man. Finally the review by Dr Buendia highlights the emerging issue of liver-cancer genetics.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10936070     DOI: 10.1006/scbi.2000.0321

Source DB:  PubMed          Journal:  Semin Cancer Biol        ISSN: 1044-579X            Impact factor:   15.707


  77 in total

Review 1.  Hepatitis B virus-induced oncogenesis.

Authors:  Joachim Lupberger; Eberhard Hildt
Journal:  World J Gastroenterol       Date:  2007-01-07       Impact factor: 5.742

2.  About seed and soil.

Authors:  Patrizia Paterlini-Bréchot
Journal:  Cancer Microenviron       Date:  2014-12

Review 3.  Molecular Pathogenesis of Liver Cancer.

Authors:  Mehmet Ozturk; Tugce Batur; Umut Ekin; Aybike Erdogan; Evin İscan; Umur Keles; Ozden Oz; Cigdem Ozen
Journal:  J Gastrointest Cancer       Date:  2017-09

4.  The effects of hepatitis B virus integration into the genomes of hepatocellular carcinoma patients.

Authors:  Zhaoshi Jiang; Suchit Jhunjhunwala; Jinfeng Liu; Peter M Haverty; Michael I Kennemer; Yinghui Guan; William Lee; Paolo Carnevali; Jeremy Stinson; Stephanie Johnson; Jingyu Diao; Stacy Yeung; Adrian Jubb; Weilan Ye; Thomas D Wu; Sharookh B Kapadia; Frederic J de Sauvage; Robert C Gentleman; Howard M Stern; Somasekar Seshagiri; Krishna P Pant; Zora Modrusan; Dennis G Ballinger; Zemin Zhang
Journal:  Genome Res       Date:  2012-01-20       Impact factor: 9.043

Review 5.  The evolution and clinical impact of hepatitis B virus genome diversity.

Authors:  Peter A Revill; Thomas Tu; Hans J Netter; Lilly K W Yuen; Stephen A Locarnini; Margaret Littlejohn
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2020-05-28       Impact factor: 46.802

Review 6.  Viruses associated with human cancer.

Authors:  Margaret E McLaughlin-Drubin; Karl Munger
Journal:  Biochim Biophys Acta       Date:  2007-12-23

Review 7.  Individualized hepatocellular carcinoma risk: the challenges for designing successful chemoprevention strategies.

Authors:  Cristina Della Corte; Alessio Aghemo; Massimo Colombo
Journal:  World J Gastroenterol       Date:  2013-03-07       Impact factor: 5.742

8.  Involvement of Crm1 in hepatitis B virus X protein-induced aberrant centriole replication and abnormal mitotic spindles.

Authors:  Marshonna Forgues; Michael J Difilippantonio; Steven P Linke; Thomas Ried; Kunio Nagashima; Jeffrey Feden; Kristoffer Valerie; Kenji Fukasawa; Xin W Wang
Journal:  Mol Cell Biol       Date:  2003-08       Impact factor: 4.272

9.  A pre-S gene chip to detect pre-S deletions in hepatitis B virus large surface antigen as a predictive marker for hepatoma risk in chronic hepatitis B virus carriers.

Authors:  Fan-Ching Shen; Ih-Jen Su; Han-Chieh Wu; Yi-Hsuan Hsieh; Wei-Jen Yao; Kung-Chia Young; Tsung-Chuan Chang; Hui-Chuan Hsieh; Han-Ni Tsai; Wenya Huang
Journal:  J Biomed Sci       Date:  2009-09-15       Impact factor: 8.410

10.  Hepatitis B virus pre-S deletion mutations are a risk factor for hepatocellular carcinoma: a matched nested case-control study.

Authors:  Zhong-Liao Fang; Caroline A Sabin; Bai-Qing Dong; Shao-Chao Wei; Qin-Yan Chen; Kong-Xiong Fang; Jin-Ye Yang; Jian Huang; Xue-Yan Wang; Tim J Harrison
Journal:  J Gen Virol       Date:  2008-11       Impact factor: 3.891

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.